Capricor Therapeutics
CAPR
#4849
Rank
S$2.37 B
Marketcap
S$41.27
Share price
6.61%
Change (1 day)
217.35%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: S$2.37 Billion

As of April 2026 Capricor Therapeutics has a market cap of S$2.37 Billion. This makes Capricor Therapeutics the world's 4849th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.37 B17.76%
2025S$2.01 B135.74%
2024S$0.85 B329.95%
2023S$0.19 B52.25%
2022S$0.13 B36.34%
2021S$95.79 M2.6%
2020S$93.37 M935.08%
2019S$9.02 M-48.69%
2018S$17.58 M-67.64%
2017S$54.33 M-34.05%
2016S$82.38 M16.57%
2015S$70.67 M21.83%
2014S$58 M20.53%
2013S$48.12 M1776.59%
2012S$2.56 M-90.85%
2011S$28.02 M1.34%
2010S$27.65 M-39.89%
2009S$46.01 M56.74%
2008S$29.35 M-84.61%
2007S$0.19 B4018.78%
2006S$4.63 M-43.33%
2005S$8.17 M2.06%
2004S$8 M22.38%
2003S$6.54 M-64.33%
2002S$18.34 M

End of Day market cap according to different sources

On Apr 2nd, 2026 the market cap of Capricor Therapeutics was reported to be:

S$2.37 Billion
by Nasdaq info icon info icon
S$2.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$752.84 B 31,616.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$16.97 B 615.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$10.56 B 345.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$2.65 B 11.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$40.36 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$7.51 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA